Oncomine™ Dx Express Test

P240040S005 · Life Technologies Corporation · PQP · Sep 9, 2026

Device Facts

Record IDP240040S005
Device NameOncomine™ Dx Express Test
ApplicantLife Technologies Corporation
Product CodePQP
Decision DateSep 9, 2026
DecisionAPPR
Device ClassClass 3

Regulatory Classification

Identification

A next generation sequencing (NGS) oncology panel is a device used for the qualitative detection of germline or somatic variants in one or more cancer-related genes. The device is intended to be used on DNA or RNA isolated from human clinical specimens.

Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...